News & Updates

Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer
Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer
27 Apr 2022

In patients with high-risk or unfavourable nonmetastatic prostate cancer (nmPC) receiving local definite therapy, the intensification of systemic therapy using chemotherapy or an androgen receptor signaling inhibitor (ARSI), in combination with androgen deprivation therapy (ADT), leads to better oncologic survival measures, reports a recent meta-analysis.

Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer
27 Apr 2022
Intensive urate lowering of little benefit to patients with erosive gout
Intensive urate lowering of little benefit to patients with erosive gout
27 Apr 2022
Asivatrep cream safe, effective for atopic dermatitis
Asivatrep cream safe, effective for atopic dermatitis
26 Apr 2022